Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
BMC Complement Med Ther. 2022 Dec 1;22(1):317. doi: 10.1186/s12906-022-03798-5.
Drug-induced mitochondrial toxicity is thought to be a common mechanism of drug hepatotoxicity. Xian-Ling-Gu-Bao (XLGB) oral preparation is a commonly used drug for osteoporosis in China. Classical safety evaluation studies have shown that the entire preparation and six Chinese herbal medicines have high safety, but the incidence of drug-induced liver damage due to XLGB remains high, the mechanism and toxic substances causing liver injury are still unclear. The purpose of this study is to identify compounds with potential mitochondrial liabilities in XLGB, and to clarify their underlying mechanisms and related pathways.
The mitochondrial function analysis was performed using an extracellular flux assay, which simultaneously monitored both oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). Through network pharmacology and in vitro experimental verification, the potential protein targets, signaling pathways and molecular mechanism of mitochondrial toxicity have been studied.
We observed a significant decrease in mitochondrial respiration of Psoraleae Fructus and its five compounds in fundamental bioenergetics parameters such as basal respiration, ATP-linked production and maximal respiration, indicating mitochondrial dysfunction. The network pharmacology results showed that the influence of XLGB on mitochondrial dysfunction was closely related to PI3K-Akt signaling pathway, mTOR signaling pathway and Apoptosis. Western blot showed that the levels of mTOR, p-mTOR (Ser2448), Raptor, PI3K (p110α), Beclin 1, ATG5 and Caspase-9 were up-regulated after treatment with psoralidin, psoralen and bavachin, and the expression of Bcl-2 was down-regulated after bavachinin treatment.
The hepatotoxicity of XLGB is associated with mitochondrial dysfunction. Five compounds in Psoraleae Fructus showed mitochondrial damage, they are psoralidin, isobavachalcone, bavachinin, bavachin and psoralen, especially psoralidin showed significant reduction in reserve capacity and respiratory control ratios. The molecular mechanism is related to the activation of PI3K/mTOR signaling pathway to inhibit autophagy and induce mitochondrial apoptosis.
药物诱导的线粒体毒性被认为是药物肝毒性的常见机制。仙灵骨葆口服制剂是中国常用的骨质疏松症药物。经典的安全性评价研究表明,整个制剂和六种中草药安全性高,但由于 XLGB 引起的药物性肝损伤仍居高不下,其肝损伤的机制和有毒物质仍不清楚。本研究旨在鉴定 XLGB 中具有潜在线粒体毒性的化合物,并阐明其潜在机制和相关途径。
采用细胞外通量分析方法进行线粒体功能分析,同时监测耗氧率(OCR)和细胞外酸化率(ECAR)。通过网络药理学和体外实验验证,研究了潜在的蛋白靶点、信号通路和线粒体毒性的分子机制。
我们观察到补骨脂及其五种化合物的基本生物能量学参数,如基础呼吸、ATP 连接生成和最大呼吸均显著降低,表明线粒体功能障碍。网络药理学结果表明,XLGB 对线粒体功能障碍的影响与 PI3K-Akt 信号通路、mTOR 信号通路和细胞凋亡密切相关。Western blot 显示,在处理补骨脂素、补骨脂素和补骨脂定后,mTOR、p-mTOR(Ser2448)、Raptor、PI3K(p110α)、Beclin 1、ATG5 和 Caspase-9 的水平上调,而 bavachinin 处理后 Bcl-2 的表达下调。
XLGB 的肝毒性与线粒体功能障碍有关。补骨脂中的五种化合物显示出线粒体损伤,它们是补骨脂素、异补骨脂查尔酮、补骨脂定、补骨脂素和补骨脂素,特别是补骨脂素显示出储备能力和呼吸控制比显著降低。分子机制与激活 PI3K/mTOR 信号通路抑制自噬并诱导线粒体凋亡有关。